TRAVATAN Z Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Travatan Z, and what generic alternatives are available?
Travatan Z is a drug marketed by Sandoz and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.
This drug has forty-five patent family members in twenty-three countries.
The generic ingredient in TRAVATAN Z is travoprost. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the travoprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Travatan Z
A generic version of TRAVATAN Z was approved as travoprost by CHARTWELL RX on March 1st, 2013.
Summary for TRAVATAN Z
International Patents: | 45 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 53 |
Patent Applications: | 3,814 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRAVATAN Z |
Drug Sales Revenues: | Drug sales revenues for TRAVATAN Z |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRAVATAN Z |
What excipients (inactive ingredients) are in TRAVATAN Z? | TRAVATAN Z excipients list |
DailyMed Link: | TRAVATAN Z at DailyMed |
Recent Clinical Trials for TRAVATAN Z
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Hong Kong | N/A |
Laboratorios Sophia S.A de C.V. | Phase 1 |
Novartis Pharmaceuticals | Phase 4 |
Pharmacology for TRAVATAN Z
Drug Class | Prostaglandin Analog |
Anatomical Therapeutic Chemical (ATC) Classes for TRAVATAN Z
Paragraph IV (Patent) Challenges for TRAVATAN Z
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TRAVATAN Z | Ophthalmic Solution | travoprost | 0.004% | 021994 | 1 | 2009-02-19 |
US Patents and Regulatory Information for TRAVATAN Z
TRAVATAN Z is protected by three US patents.
Patents protecting TRAVATAN Z
Self preserved aqueous pharmaceutical compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Self-preserved aqueous pharmaceutical compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Self preserved aqueous pharmaceutical compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRAVATAN Z
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for TRAVATAN Z
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Novartis Europharm Limited | Izba | travoprost | EMEA/H/C/002738 Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1). Decrease of elevated intraocular pressure in paediatric patients aged 3 years to < 18 years with ocular hypertension or paediatric glaucoma. |
Authorised | no | no | no | 2014-02-20 | |
Novartis Europharm Limited | Travatan | travoprost | EMEA/H/C/000390 Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1).Decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma (see section 5.1). |
Authorised | no | no | no | 2001-11-27 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for TRAVATAN Z
See the table below for patents covering TRAVATAN Z around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Chile | 2007002705 | COMPOSICION FARMACEUTICA OFTALMICA AUTOPRESERVADA QUE COMPRENDE 0,04 A 0,9 MM DE IONES ZINC DONDE LA CONCENTRACION DE ANIONES TAMPONANTES ES MENOR QUE 15 MM. | ⤷ Try a Trial |
Mexico | 2009002221 | COMPOSICIONES FARMACEUTICAS ACUOSAS AUTO-PRESERVADAS. (SELF PRESERVED AQUEOUS PHARMACEUTICAL COMPOSITIONS.) | ⤷ Try a Trial |
Portugal | 639563 | ⤷ Try a Trial | |
Japan | 5411897 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TRAVATAN Z
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1920764 | 12C0045 | France | ⤷ Try a Trial | PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001 20011127 |
1920764 | 92058 | Luxembourg | ⤷ Try a Trial | 92058, EXPIRES: 20161127 |
1920764 | 2012/033 | Ireland | ⤷ Try a Trial | PRODUCT NAME: TRAVOPROST (ALSO CALLED FLUPROSTENOL ISOPROPYL ESTER); NAT REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; FIRST REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; PAEDIATRIC INVESTIGATION PLAN: P/0298/2013 PROCEEDINGS UNDER SECTION 37 OF THE PATENTS ACT, 1992 RESTORATION ORDER DATED 12TH JANUARY 2016, WAS MADE RESTORING THE PATENT MENTIONED BELOW S85583 PAUL DOYLE A RE-USABLE BAG SYSTEM RESTORATION ORDERS DATED 16TH FEBRUARY 2016, WERE MADE RESTORING THE PATENTS MENTIONED BELOW S86133 MERVYN GREENE MULTI PURPOSE TANK STAND WITH COMPLEX LOCKING MECHANISM 86119 MPC GREEN LIMITED ANEW BIN |
1514548 | C300671 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EG EU/1/01/199/001-002 20011128 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |